Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in Australia(legacy) | 123 |
| What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in Australia(legacy) | 99 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in Australia | 1 | 5 | 3 | 1 | 1 | 7 | 2 |
File Downloads
| Views | |
|---|---|
| hdl_108495.pdf(legacy) | 96 |
| hdl_108495.pdf | 61 |
| null(legacy) | 1 |
Top Country Views
| Views | |
|---|---|
| United States | 81 |
| Australia | 56 |
| China | 13 |
| Vietnam | 11 |
| Netherlands | 8 |
| Germany | 7 |
| France | 6 |
| Brazil | 4 |
| Sweden | 3 |
| Turkey | 3 |
Top City Views
| Views | |
|---|---|
| Ashburn | 31 |
| Kaleen | 29 |
| Fairfield | 12 |
| Hanoi | 11 |
| Adelaide | 10 |
| Rotterdam | 8 |
| Dearborn | 5 |
| Des Moines | 4 |
| New York | 4 |
| Sydney | 4 |